Cetera Advisors LLC Amarin Corp Plcuk Transaction History

Cetera Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$4.0 - $21.53 $43,780 - $235,645	-10,945 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$13.94 - $24.12 $152,573 - $263,993	10,945 New	10,945 $237,000
Q3 2019 Nov 06, 2019	SELL	$13.89 - $23.16 $921,323 - $1.54 Million	-66,330 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$16.27 - $20.51 $159,494 - $201,059	-9,803 Reduced 12.88%	66,330 $1.31 Million
Q1 2019 May 06, 2019	BUY	$12.61 - $22.33 $66,643 - $118,014	5,285 Added 7.46%	76,133 $1.56 Million
Q4 2018 Feb 15, 2019	BUY	$12.41 - $22.98 $683,580 - $1.27 Million	55,083 Added 349.4%	70,848 $942,000
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $232 - $1,545	95 Added 0.61%	15,765 $257,000
Q2 2018 Aug 14, 2018	BUY	$2.68 - $3.48 $2,680 - $3,480	1,000 Added 6.82%	15,670 $49,000
Q1 2018 May 09, 2018	BUY	$2.99 - $4.44 $6,727 - $9,990	2,250 Added 18.12%	14,670 $45,000
Q4 2017 Feb 08, 2018	BUY	$3.06 - $4.09 $612 - $818	200 Added 1.64%	12,420 $49,000
Q3 2017 Nov 16, 2017	BUY	$3.03 - $3.72 $606 - $744	200 Added 1.66%	12,220 $43,000
Q2 2017 Aug 14, 2017	BUY	N/A	12,020	12,020 $48,000

183

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.